Demyelinating disease in a patient with cerebral venous thrombosis and covid-19 clinical manifestations
- Authors: Klocheva Y.G.1, Olimova F.Z.1, Goldobin V.V.1, Bogatenkova J.D.2
-
Affiliations:
- North-Western State Medical University named after I.I. Mechnikov
- City Consulting and Diagnostic Center No. 1
- Issue: Vol LIV, No 2 (2022)
- Pages: 85-95
- Section: Case reports
- URL: https://journals.rcsi.science/1027-4898/article/view/104446
- DOI: https://doi.org/10.17816/nb104446
- ID: 104446
Cite item
Abstract
Actually, verifying neurological disorders associated with COVID-19 make clinicians ask several questions: the manifestation of neurological pathology is due to COVID-19, or there is a combination of several CNS pathologies with COVID-19. We report a clinical case of a 57-year-old female patient with demyelinating disease of the central nervous system, cerebral venous thrombosis associated with clinically transferred COVID-19. Differential diagnosis was performed with multiple sclerosis, acute multiple encephalomyelitis, opticomyelitis, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, sarcoidosis, antiphospholipid syndrome, mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) and thrombosis veins of the large hemispheres. Probable pathogenetic variants of demyelination development and possible connection with cerebral venous thrombosis and COVID-19 are highlighted.
Full Text
##article.viewOnOriginalSite##About the authors
Yelena G. Klocheva
North-Western State Medical University named after I.I. Mechnikov
Email: klocheva@mail.ru
ORCID iD: 0000-0001-6814-0454
M.D, Dr. Sci. (Med.), Professor
Russian Federation, St. PetersburgFarakhnoz Z. Olimova
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: farahnoz.zafarovna1994@gmail.com
ORCID iD: 0000-0003-2239-0073
SPIN-code: 5339-9323
postgraduate student
Russian Federation, St. PetersburgVitalii V. Goldobin
North-Western State Medical University named after I.I. Mechnikov
Email: Goldobin@szgmu.ru
ORCID iD: 0000-0001-9245-8067
SPIN-code: 4344-5782
M.D., Dr. Sci. (Med.), Professor
Russian Federation, St. PetersburgJulia D. Bogatenkova
City Consulting and Diagnostic Center No. 1
Email: gkdc1@zdrav.spb.ru
ORCID iD: 0000-0002-0101-715X
M.D. Cand. Sci. (Med), Head of the Stroke Prevention Center
Russian Federation, Saint-PetersburgReferences
- Mao L, Jin H, Wang M et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127.
- Han H, Ma Q, Li C et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9(1):1123–1130.
- Petkovic F, Castellano B. The role of interleukin-6 in central nervous system demyelination. Neural Regen Res. 2016;11(12):1922.
- Ghosh R, Roy D, Mandal A et al. Cerebral venous thrombosis in COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(3):1039–1045.
- Bikdeli B, Madhavan MV, Jimenez D et al. Global COVID-19 thrombosis collaborative group. J Am Coll Cardiol. 2020;75(23):2950e73. doi: 10.1016/j.jacc.2020.04.031.
- Rae-Grant AD, Wong C, Bernatowicz R et al. Observations on the brain vasculature in multiple sclerosis: a historical perspective. Mult Scler Relat Disord. 2014;3:156–162.
- Haacke EM, Yulin Ge, Sean KS et al. An overview of venous abnormalities related to the development of lesions in multiple sclerosis. Frontiers in Neurology. 2021;12:589.
- Adams CWM, Poston RN, Buk SJ et al. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci. 1985;69:269–283. doi: 10.1016/0022-510X(85)90139-X.
- Adams CWM. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci. 1975;25:165–182. doi: 10.1016/0022-510X(75)90138-0.
- Keith J, Gao FQ, Noor R et al. Collagenosis of the deep medullary veins: An underrecognized pathologic correlate of white matter hyperintensities and periventricular infarction? J Neuropathol Exp Neurol. 2017;76:299–312. doi: 10.1093/jnen/nlx009.
- Zamboni P, Galeotti R, Menegatti E et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80:392–399. doi: 10.1136/jnnp.2008.157164.
- Zivadinov R, Marr K, Cutter G et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 2011;77:138–144. doi: 10.1212/WNL.0b013e318212a901.
- Trifan G, Sethi S, Elias S et al. Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis. Neurol Res. 2012;34:780–792. doi: 10.1179/1743132812Y.0000000078.
- Veroux P, Giaquinta A, Perricone D et al. Internal jugular veins outflow in patients with multiple sclerosis: A catheter venography study. J Vasc Interv Radiol. 2013;24:1790–1797. doi: 10.1016/j.jvir.2013.08.024.
- Lee BB, Baumgartner I, Berlien P et al. Diagnosis and treatment of venous malformations. consensus document of the International Union of Phlebology (IUP): updated 2013. Int Angiol. 2015;34:97–149.
- Gadda G, Taibi A, Sisini F et al. A new hemodynamic model for the study of cerebral venous outflow. Am J Physiol Hear Circ Physiol. 2015;308:H217–31. doi: 10.1152/ajpheart.00469.2014.
- Toro E, Muller L, Cristini M et al. Impact of jugular vein valve function on cerebral venous haemodynamics. Curr Neurovasc Res. 2015;12:384–397. doi: 10.2174/1567202612666150807112357.
- Bagert BA, Marder E, Stüve O. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Arch Neurol. 2011;68(11):1379–1384. doi: 10.1001/archneurol.2011.179. PMID: 21747006.
- Graham EM, Stanford MR, Sanders MD et al. A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol. 1989;73:714–721. doi: 10.1136/bjo.73.9.714.
- Ginsberg MD, Hedley-Whyte ET, Richardson EP. Hypoxic-ischemic leukoencephalopathy in man. Arch Neurol. 1976;33:5–14. doi: 10.1001/archneur.1976.00500010007002.